Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model

Journal of Immunology

Volumn 183, Issue 10, 2009, Pages 6489-6499

  Luangsay, Souphalone ^a   Wittamer, Valérie ^a   Bondue, Benjamin ^a   De Henau, Olivier ^a   Rouger, Laurie ^a   Brait, Maryse ^b   Franssen, Jean Denis ^b   De Nadai, Patricia ^a   Huaux, François ^c   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Euroscreen SA   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHEMERIN; CHEMOATTRACTANT; LIPOPOLYSACCHARIDE; PROCHEMERIN; PROTEIN CHEMR23; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM MOBILIZATION; CARBOXY TERMINAL SEQUENCE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EPITHELIUM CELL; IMMUNE RESPONSE; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; LEUKOCYTE; LUNG DISEASE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ACUTE DISEASE; AEQUORIN; ANIMALS; APOPROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; CALCIUM; CHEMOTACTIC FACTORS; CHEMOTAXIS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PEPTIDES; PNEUMONIA; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT PROTEINS;

EID: 77649137835     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901037     Document Type: Article

References (60)

1. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18: 593-620.
2. Ebert, L. M., P. Schaerli, and B. Moser. 2005. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol. Immunol. 42: 799-809.
3. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
4. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
5. Foti, M., F. Granucci, and P. Ricciardi-Castagnoli. 2004. A central role for tissue-resident dendritic cells in innate responses. Trends Immunol. 25: 650-654.
6. Bonasio, R., and U. H. von Andrian. 2006. Generation, migration and function of circulating dendritic cells. Curr. Opin. Immunol. 18: 503-511. (Pubitemid 43947581)
7. Banchereau, J., B. Schuler-Thurner, A. K. Palucka, and G. Schuler. 2001. Dendritic cells as vectors for therapy. Cell 106: 271-274.
8. Liu, Y. J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106: 259-262.
9. Villadangos, J. A., and P. Schnorrer. 2007. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7: 543-555.
10. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2: 361-367.
11. Cella, M., D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, and M. Colonna. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5: 919-923.
12. Yoneyama, H., K. Matsuno, Y. Zhang, T. Nishiwaki, M. Kitabatake, S. Ueha, S. Narumi, S. Morikawa, T. Ezaki, B. Lu, et al. 2004. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 16: 915-928.
13. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
14. Penna, G., S. Sozzani, and L. Adorini. 2001. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167: 1862-1866. (Pubitemid 32747488)
15. de la Rosa, G., N. Longo, J. L. Rodriguez-Fernandez, A. Puig-Kroger, A. Pineda, A. L. Corbi, and P. Sanchez-Mateos. 2003. Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subset-specific transmigration. J. Leukocyte Biol. 73: 639-649.
16. Diacovo, T. G., A. L. Blasius, T. W. Mak, M. Cella, and M. Colonna. 2005. Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J. Exp. Med. 202: 687-696.
17. Wendland, M., N. Czeloth, N. Mach, B. Malissen, E. Kremmer, O. Pabst, and R. Forster. 2007. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl. Acad. Sci. USA 104: 6347-6352.
18. Wittamer, V., J. D. Franssen, M. Vulcano, J. F. Mirjolet, E. Le Poul, I. Migeotte, S. Brezillon, R. Tyldesley, C. Blanpain, M. Detheux, et al. 2003. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198: 977-985.
19. Adams, A. E., Y. Abu-Amer, J. Chappel, S. Stueckle, F. P. Ross, S. L. Teitelbaum, and L. J. Suva. 1999. 1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast-supporting stromal cells. J. Cell. Biochem. 74: 587-595.
20. Meder, W., M. Wendland, A. Busmann, C. Kutzleb, N. Spodsberg, H. John, R. Richter, D. Schleuder, M. Meyer, and W. G. Forssmann. 2003. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett. 555: 495-499.
21. Parolini, S., A. Santoro, E. Marcenaro, W. Luini, L. Massardi, F. Facchetti, D. Communi, M. Parmentier, A. Majorana, M. Sironi, et al. 2007. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109: 3625-3632.
22. Vermi, W., E. Riboldi, V. Wittamer, F. Gentili, W. Luini, S. Marrelli, A. Vecchi, J. D. Franssen, D. Communi, L. Massardi, et al. 2005. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201: 509-515.
23. Wittamer, V., F. Gregoire, P. Robberecht, G. Vassart, D. Communi, and M. Parmentier. 2004. The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 279: 9956-9962.
24. Wittamer, V., B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, and D. Communi. 2005. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J. Immunol. 175: 487-493. (Pubitemid 40884353)
25. Zabel, B. A., S. J. Allen, P. Kulig, J. A. Allen, J. Cichy, T. M. Handel, and E. C. Butcher. 2005. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J. Biol. Chem. 280: 34661-34666.
26. Albanesi, C., C. Scarponi, S. Pallotta, R. Daniele, D. Bosisio, S. Madonna, P. Fortugno, S. Gonzalvo-Feo, J. D. Franssen, M. Parmentier, et al. 2009. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 206: 249-258.
27. Nagpal, S., S. Patel, H. Jacobe, D. DiSepio, C. Ghosn, M. Malhotra, M. Teng, M. Duvic, and R. A. S. Chandraratna. 1997. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J. Invest. Dermatol. 109: 91-95.
28. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8: 594-606.
29. Cash, J. L., R. Hart, A. Russ, J. P. Dixon, W. H. Colledge, J. Doran, A. G. Hendrick, M. B. Carlton, and D. R. Greaves. 2008. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205: 767-775.
30. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
31. Guillabert, A., V. Wittamer, B. Bondue, V. Godot, V. Imbault, M. Parmentier, and D. Communi. 2008. Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J. Leukocyte Biol. 84: 1530-1538.
32. Methner, A., G. Hermey, B. Schinke, and I. HermansBorgmeyer. 1997. A novel G protein-coupled receptor with homology to neuropeptide and chemoattractant receptors expressed during bone development. Biochem. Biophys. Res. Commun. 233: 336-342.
33. Martensson, U. E., C. Owman, and B. Olde. 2004. Genomic organization and promoter analysis of the gene encoding the mouse chemoattractant-like receptor, CMKLR1. Gene 328: 167-176.
34. Martensson, U. E., J. Bristulf, C. Owman, and B. Olde. 2005. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid. Gene 350: 65-77.
35. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone-marrow cultures supplemented with granulocyte macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
36. Arita, M., F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N. A. Petasis, and C. N. Serhan. 2005. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201: 713-722.
37. Arita, M., T. Ohira, Y. P. Sun, S. Elangovan, N. Chiang, and C. N. Serhan. 2007. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178: 3912-3917. (Pubitemid 46417661)
38. Barnea, G., W. Strapps, G. Herrada, Y. Berman, J. Ong, B. Kloss, R. Axel, and K. J. Lee. 2008. The genetic design of signaling cascades to record receptor activation. Proc. Natl. Acad. Sci. USA 105: 64-69.
39. Farzan, M., H. Choe, K. Martin, L. Marcon, W. Hofmann, G. Karlsson, Y. Sun, P. Barrett, N. Marchand, N. Sullivan, et al. 1997. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186: 405-411.
40. Zabel, B. A., T. Ohyama, L. Zuniga, J. Y. Kim, B. Johnston, S. J. Allen, D. G. Guido, T. M. Handel, and E. C. Butcher. 2006. Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-βand TLR ligands. Exp. Hematol. 34: 1106-1114.
41. Zabel, B. A., A. M. Silverio, and E. C. Butcher. 2005. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J. Immunol. 174: 244-251.
42. Bilyk, N., and P. G. Holt. 1993. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 177: 1773-1777. (Pubitemid 23146144)
43. Bilyk, N., and P. G. Holt. 1995. Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology 86: 231-237.
44. Holt, P. G., J. Oliver, N. Bilyk, C. McMenamin, P. G. McMenamin, G. Kraal, and T. Thepen. 1993. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177: 397-407.
45. Bingisser, R. M., and P. G. Holt. 2001. Immunomodulating mechanisms in the lower respiratory tract: nitric oxide mediated interactions between alveolar macrophages, epithelial cells, and T-cells. Swiss Med. Wkly. 131: 171-179.
46. Strickland, D. H., T. Thepen, U. R. Kees, G. Kraal, and P. G. Holt. 1993. Regulation of T-cell function in lung tissue by pulmonary alveolar macrophages. Immunology 80: 266-272.
47. Strickland, D., U. R. Kees, and P. G. Holt. 1996. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology 87: 250-258. (Pubitemid 26060587)
48. Hongo, D., J. S. Bryson, A. M. Kaplan, and D. A. Cohen. 2004. Endogenous nitric oxide protects against T cell-dependent lethality during graft-versus-host disease and idiopathic pneumonia syndrome. J. Immunol. 173: 1744-1756.
49. Phipps, R. P., S. H. Stein, and R. L. Roper. 1991. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12: 349-352.
50. Rangel, M. J., G. Estrada, I. De La Luz Garcia Hernandez, L. D. Aguilar, R. Marquez, and P. R. Hernandez. 2002. The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106: 257-266.
51. Ballinger, M. N., D. M. Aronoff, T. R. McMillan, K. R. Cooke, K. Olkiewicz, G. B. Toews, M. Peters-Golden, and B. B. Moore. 2006. Critical role of prostaglandin E2 overproduction in impaired pulmonary host response following bone marrow transplantation. J. Immunol. 177: 5499-5508.
52. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5: 405-411.
53. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
54. Chambers, B. J., M. Salcedo, and H. G. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5: 311-317.
55. Piccioli, D., S. Sbrana, E. Melandri, and N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195: 335-341.
56. Moretta, A., E. Marcenaro, S. Parolini, G. Ferlazzo, and L. Moretta. 2007. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 15: 226-233.
57. Liu, C., Y. Lou, G. Lizee, H. Qin, S. Liu, B. Rabinovich, G. J. Kim, Y. H. Wang, Y. Ye, A. G. Sikora, et al. 2008. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J. Clin. Invest. 118: 1165-1175.
58. Goralski, K. B., T. C. McCarthy, E. A. Hanniman, B. A. Zabel, E. C. Butcher, S. D. Parlee, S. Muruganandan, and C. J. Sinal. 2007. Chemerin: a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282: 28175-28188.
59. Bozaoglu, K., K. Bolton, J. McMillan, P. Zimmet, J. Jowett, G. Collier, K. Walder, and D. Segal. 2007. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148: 4687-4694.
60. Roh, S. G., S. H. Song, K. C. Choi, K. Katoh, V. Wittamer, M. Parmentier, and S. Sasaki. 2007. Chemerin: a new adipokine that modulates adipogenesis via its own receptor. Biochem. Biophys. Res. Commun. 362: 1013-1018.